Article
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.
World journal of urology - 1 Jun 2012
Nadiminty Nagalakshmi, Gao Allen C
Abstract excerpt
BACKGROUND: The emergence of castration resistance has remained the primary obstacle in prostate cancer therapy for several decades. Mechanisms likely to be involved in castration-resistant progression have been studied extensively, but have failed to yield many meaningful and effective targets. The re-activation of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC) is now recognized as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
